Industry Symposium: Novartis

16 Jan 2018
07:45-08:45
Charter 2 & 3
Back

Industry Symposium: Novartis

MDT live: Clinical case decision making at the front line

07.45-07.50
Welcome and introduction
Dr Mark Verrill
07.50 – 07.55
Introducing CDK pathway inhibition
– A milestone moment for metastatic
breast cancer
Professor Andrew Wardley
07.55 – 08.40
Informed decisions with ribociclib –
decision making and practical advice
for first-line HR+/HER2-locally
advanced or metastatic breast cancer
Dr Mark Verrill (Chair); Professor Andrew
Wardley; Professor Samreen Ahmed; Dr
Vickki Harmer

08.40 – 08.45
Concluding remarks
Dr Mark Verrill